Director, Regulatory Affairs Strategy

2 days ago


Cambridge, Massachusetts, United States BlueRock Therapeutics Full time

Who is BlueRock?

BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson's disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.

What Are We Doing?

Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.

We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients' lives.

We are seeking an experienced and strategic Director, Regulatory Affairs Strategy to lead global regulatory activities for our cell therapy programs as the Global Regulatory Lead on assigned program(s). The successful candidate will play a critical role in shaping regulatory strategy, leading health authority interactions, and supporting the preparation and submission of regulatory documentation across the development lifecycle. This is a highly cross-functional role requiring collaboration with Clinical, CMC, Nonclinical, Quality, and Program Management teams to ensure alignment of regulatory strategy with corporate objectives. This position is responsible for the development and implementation of global regulatory strategy on assigned programs, working closely with the nonclinical and clinical teams, and may represent the Regulatory Affairs function on various subcommittees. This individual will guide and/or lead the generation of dossiers in conjunction with Regulatory CMC and Device colleagues to support Health Authority meetings, clinical trial applications and market applications in the US and ex-US territories. Expertise and knowledge of global regulations and guidance for the development of advanced therapies is required.

Responsibilities:
  • Develop overall regulatory strategy for assigned programs, working closely with the nonclinical and clinical teams, in conjunction with the Regulatory CMC and Device leads
  • Provide regulatory leadership as the Global Regulatory Lead to program teams and subteams as the go to point of contact for regulatory strategy on assigned program(s)
  • Lead the Regulatory Strategy Subteam(s) in the development of global regulatory plans to support assigned program(s)
  • Collaboratively identify regulatory risks to product development and design risk mitigation strategies as aligned with cross-functional SMEs
  • Provide regulatory support and contribute to the development and implementation of regulatory strategies to support the approval and commercialization of assigned products in compliance with applicable Health Authority requirements, including the identification of gaps or risks and opportunities to expedite development through innovative pathways
  • Collaborate cross-functionally with internal teams and subject matter experts to provide regulatory guidance and support throughout the product lifecycle and to prepare regulatory submissions (eg, meeting requests, briefing documents, IND/CTA filings, marketing applications, designation requests, etc…)
  • Lead content development, organization, and coordination of cross functional regulatory submissions (e.g., INDs, CTAs, BLA, etc…)
  • Author, coordinate, review, and execute submissions and responses to regulatory authorities related to INDs, CTAs, amendments, Information Requests, within appropriate timelines and in accordance with regulations and guidelines.
  • Maintain detailed knowledge of the evolving global regulatory landscape relevant for advanced therapies including accelerated review programs. Assess the impact of new regulations/guidance on internal programs and communicate relevant changes to internal stakeholders
  • Contribute to regulatory department initiatives to develop procedures and working practices
Minimum Requirements:
  • Strong knowledge of US and international regulations and ICH guidelines
  • BS or MS degree in a scientific discipline or related field is required; MS/PhD preferred.
  • Minimum of 8 years of experience in Regulatory Affairs, with at least some experience in cell or gene therapy.
  • Demonstrated experience with regulatory products to treat rare diseases and/or unmet medical needs (eg, orphan products, fast track, RMAT, breakthrough therapies, PRIME).
  • Demonstrated experience with INDs/ CTAs and life cycle experience. Some experience in cell or gene therapy required. International regulatory experience a plus
  • Experience preparing documents for regulatory filings including IND/CTA, NDA/BLA/MAA, lifecycle management, interactions with health authorities
  • Experience developing and implementing complex regulatory strategies
  • Experience developing briefing documents and interfacing with regulatory agencies
  • Evidence of being a critical strategic thinker who is solution oriented with the ability to think outside of the box
  • Ability to set priorities, work independently, deliver results in a timely manner and adapt and react to new information or changing priorities
  • Strong organizational and planning skills, and ability to communicate effectively and efficiently to multiple audiences
  • Excellent written and oral communication skills with attention to detail. Highly computer literate (Word, Excel PowerPoint), including formatting documents for regulatory submission.
  • Ability to travel within US/Canada (and some additional, limited EU travel possible) up to 20% is required.

$200,000 - $230,000 a year

$200,000 - $230,000

LI-AL1

BlueRock Therapeutics Company Culture Highlights

Winner of Boston Business Journal's Best Places to Work (Mid-size Company) 2023

Winner of Comparably's Award for Best Company for Diversity 2022

Winner of Comparably's Award for Best Company for Women 2022

Winner of Comparably's Award for Best CEO 2022

BlueRock Therapeutics is ranked in the top 5% of companies for Overall Culture on Comparably.

Engineering Department is ranked in the top 5% of companies for Overall Culture on Comparably.

Equal Opportunity Workplace:At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

Perks and Benefits

Health & Wellness

Dental Insurance

Vision Insurance

Health Insurance

Life Insurance

Gym Membership / Reimbursement

Paid Time Off

PTO / Vacation Policy

Paid Holidays

Maternity / Paternity Leave

Financial Benefits

401K / Retirement Plan

Performance Bonus

Office Perks

Company Social Outings

Unique Office Space

Free Food

Work From Home Policy



  • Cambridge, Massachusetts, United States City Therapeutics Full time $200,000 - $250,000 per year

    Reporting to the SVP, Head of Regulatory Affairs, the Director of CMC Regulatory Affairs will be responsible for leading Chemistry, Manufacturing, and Controls (CMC) regulatory strategy and execution for products in the development pipeline. This role will work independently to provide strategic leadership on global regulatory submissions and ensure...


  • Cambridge, Massachusetts, United States City Therapeutics Full time

    Reporting to the SVP, Head of Regulatory Affairs, the Director, Regulatory Affairs – Global Regulatory Lead will serve as the primary global regulatory strategist for assigned products across all phases of development and commercialization. This individual will be responsible for developing and implementing global regulatory strategies, leading...


  • Cambridge, Massachusetts, United States Beam Therapeutics Full time $200,000 - $250,000 per year

    Company Overview:Beam Therapeutics is a clinical stage biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing...


  • Cambridge, Massachusetts, United States Cognito Therapeutics Full time

    Director, Medical Affairs, Cognito Therapeutics, Inc.Location: Boston, MA, Full-timeCompany DescriptionCognito Therapeutics, Inc. is a venture-backed (Morningside Ventures, FoundersX, IAG, Starbloom) late clinical stage company translating scientific findings from MIT into therapeutic approaches for brain health, including Alzheimer's disease and other...


  • Cambridge, Massachusetts, United States Novartis Full time

    SummaryThe Regulatory Diagnostics Manager (RDM)Regulatory Diagnostics Associate Director (RDAD) for Precision Diagnostics is responsible for implementation of strategic plans for development of diagnostics, including Companion Diagnostics (CDx), as they pertain to the Novartis innovative medicines portfolio, including its marketed products. The RD...


  • Cambridge, Massachusetts, United States Ipsen Full time $160,000 - $210,000

    Title:Associate Director, Business Ethics, Medical Affairs & NeuroscienceCompany:Ipsen Biopharmaceuticals Inc.About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs...


  • Cambridge, Massachusetts, United States IPSEN Full time $180,750 - $265,000 per year

    The Director, Dysport Marketing - Migraine is a new, key strategic and leadership role within the Neuroscience Business Unit. This is a unique opportunity to shape the future of Dysport in a new therapeutic area and make a meaningful impact for patients living with migraine. You will be part of a passionate, collaborative team committed to innovation and...


  • Cambridge, Massachusetts, United States Ipsen Full time $150,000 - $250,000 per year

    TheDirector, Dysport Marketing - Migraineis a new, key strategic and leadership role within the Neuroscience Business Unit. This is a unique opportunity to shape the future of Dysport in a new therapeutic area and make a meaningful impact for patients living with migraine. You will be part of a passionate, collaborative team committed to innovation and...


  • Cambridge, Massachusetts, United States Sarepta Therapeutics Full time

    Why Sarepta? Why Now?The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat...


  • Cambridge, Massachusetts, United States Sarepta Therapeutics Full time

    Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to...